Hold at $529 with scaled-add zone $505–516 and volatility-adjusted stop at $485
The aggressive analyst is directionally correct on the structural regime change (first net equity purchase in 14 quarters, Q2 operating earnings +16.3% YoY, $30B Alphabet position) but entry at $529 with RSI 74.5 and 52-week highs is structurally poor. The conservative analyst is correct on the stretched tactical setup (forward P/E 24.25, RSI 74.5, 18/19 constructive headlines) but reducing exposure forfeits the structural tailwind and buyback bid at a moment when capital deployment is finally in motion. The optimal framework synthesizes both: maintain current exposure, wait for $505–516 pullback to add scaled positions, set hard stop at $485 (not $509, which guarantees whipsaw given 18% ATR expansion), trim 25–33% above $545, and re-evaluate after Q3 earnings and 13F filings. This is discipline with conviction, not indecision.
| Position | Action |
|---|---|
| Maximum portfolio weight | 5–7% of portfolio maximum; core holding, not tactical concentration |
| Add on pullback | Scale in 25% / 50% / 25% across $505–516 zone (not lump-sum) |
| Above $545 | Trim 25–33% of position — risk management, not thesis abandonment |
| Above $580 | Take further profit if momentum extends with confirmed operating earnings |
The bears are wrong at exactly the wrong time; Berkshire is in a structural inflection with cash deployment, accelerating buybacks, and a favorable macro backdrop that makes the current $529 level a compelling BUY.
| Indicator | Value | Signal |
|---|---|---|
| Close | 529.42 | neutral |
| RSI (14) | 74.54 | bearish |
| MACD Line | 8.38 | bullish |
| MACD Signal | 5.88 | bullish |
| MACD Histogram | +2.50 | bullish |
| 10 EMA | 516.61 | bullish |
| 50 SMA | 496.11 | bullish |
| 200 SMA | 491.23 | bullish |
| Bollinger Upper Band | 531.89 | neutral |
| Bollinger Middle Band | 504.23 | bullish |
| ATR (14) | 8.05 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Price at $504–505 (Bollinger middle band)
Then: Deploy remaining 50% of intended add size
EV: +3% to +13% · concedes: RSI of 74.5 is technically overbought; Forward P/E of 24.25 is above historical averages; An RSI rollover below 65 or close inside 10 EMA at $516.61 would signal short-term pullback; A 5% pullback to $504 is possible on mean reversion; Michael Burry's dissent is the lone bearish voice but carries name recognition weight
Berkshire Hathaway's Q2 "beat" is a mark-to-market mirage masking a 30% multi-year earnings decline; its transition from cash hoarding to aggressive deployment at 52-week highs signals peak valuations; and the risk-reward is asymmetric to the downside with forward P/E of 24.25, five overbought technical signals, and $60-80B concentration exposure to equity market drawdowns.
· concedes: Bull's directional thesis may be partially correct; Q2 mark-to-market bounce is real (Q2 2026 generated $25.77B net income); BRK-B's defensive characteristics are valid IF a selloff materializes (but insurance premium is being paid before the accident, at peak pricing); Post-Buffett overhang narrative is fading, reducing discount rate on succession uncertainty
→ vs conservative: Forward P/E of 24.25 dismissed as 'stretched'; TTM P/E of 15.76 is below S&P 500 and mispriced by cautious crowd
→ vs conservative: RSI overbought at 74.5 rejected; every major BRK-B uptrend has had RSI at 70-plus for weeks
→ vs conservative: Hard stop at $485 (8.3% below current) foregoes 3-5% upside to wait for pullback that may never come
→ vs conservative: Pattern-matching to mean-reversion setups inappropriate during structural regime change
→ vs conservative: Burry's credit-focused framework doesn't apply to fortress balance sheet with $365B cash and $170B float
→ vs conservative: ROE at 12% being dismissed as 'only' ignores cash deployment opportunity about to be deployed productively
→ vs neutral: Waiting for entry at $505-$516 gives up 3-5% upside chasing pullback that may not materialize
→ vs neutral: 'Discipline over FOMO' framing is managing psychology, not maximizing risk-adjusted returns
→ vs neutral: Symmetric risk-reward framing ignores structural tailwinds: buybacks, float yield, and Precision Castparts latent value
→ vs neutral: 'Anyone waiting for $505 will be paying $560 to chase' — caution manufactures the FOMO it tries to avoid
| VWMA (20) | 510.10 | bullish |
| Cycle Low (4/16/2026) | 464.01 | neutral |
| Intraday High (8/10) | 537.72 | neutral |
Support: 516.61 · 504.23 · 496.11 | Resistance: 537.72 · 545
BRK-B completed a +14% recovery from the April cycle low ($464.01) to close at $529.42, executing a confirmed breakout above the Bollinger upper band ($531.89) with RSI at 74.54 overbought and MACD histogram expanding to +2.50. The stock trades above all three moving averages (10 EMA 516.61, 50 SMA 496.11, 200 SMA 491.23) with VWMA rising to $510.10, confirming real-volume participation. The primary risk is short-term mean reversion: a pullback to $516.61 (10 EMA) or $504.23 (Bollinger middle) would be a healthy consolidation, while an RSI rollover below 65 would signal a deeper correction. Recommended action: hold existing longs; wait for tactical pullback entries near $516–$504 for new capital with stops below $496.
Market Cap
$1.142 trillion
Stock Price
$529.49
52-Week High
$537.72
52-Week Low
$463.50
50-Day Avg
$495.07
200-Day Avg
$491.03
P/E (TTM)
15.76
Forward P/E
24.25
PEG Ratio
10.06
Price/Book (normalized)
1.6x
Beta
0.607
Revenue 2025
$410,522M
Operating Income 2025
$87,528M
Net Income 2025
$66,968M
Diluted EPS 2025
$31.04
Net Income Q2 2026
$25,767M
Revenue Q2 2026
$117,885M
Diluted EPS Q2 2026
$11.91
Total Assets Q2 2026
$1,263.1B
Total Liabilities Q2 2026
$512.9B
Stockholders' Equity Q2 2026
$747.9B
Cash & ST Investments Q2 2026
$365.5B
Total Debt Q2 2026
$128.6B
Tangible Book Value Q2 2026
$630.8B
Debt/Equity
17.14%
Current Ratio
2.89
Net Income TTM
$85.8B
Operating Margin
32.56%
Net Margin
22.30%
ROE
12.12%
ROA
6.01%
Free Cash Flow 2025
$25,042M
Free Cash Flow TTM
$72.0B
Capital Expenditure 2025
$20,927M
Buybacks Q2 2026
$4.21B
Interest Income 2025
$23.3B
Insurance Float
$170B
Unrealized Losses 2025
$39.98B
H1 2026 Net Income
$35.95B
Strengths
Concerns
Berkshire Hathaway delivered a strong Q2 2026 with net income of $25.77B ($11.91 EPS), more than doubling year-ago results as prior portfolio mark-downs reversed. The company maintains exceptional fundamentals with 32.56% operating margins and $72B in trailing FCF, while the record $365.5B cash position (29% of assets) represents dry powder for future deployment. Resumed buybacks of $4.21B in Q2 signal management views BRK-B as undervalued, though normalized P/B of 1.6x leaves limited margin of safety versus the ~$529 price, and concentration risk in the equity portfolio combined with mark-to-market volatility continue to create earnings uncertainty.
Macro: Risk-off but not bearish: oil spiking on Iran/Hormuz reopening fears; equity indexes pulling back from records; prediction markets pricing sticky inflation (P(>4.5%) = 20%), no Fed cuts in 2026 (86%), and soft landing (recession 8%)—a higher-for-longer, slow-cut regime structurally friendly to a cash-rich insurer/conglomerate.